IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Crestline Management, L.P.

Q4 2025 Holdings

Filed 2026-02-17 | 3 holdings | $53.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Denali Therapeutics Inc(DNLI)COM24823R105$46.4M2,810,73287.0%
Sana Biotechnology Inc(SANA)COM799566104$5.0M1,220,9379.3%
8X8 Inc New(EGHT)COM282914100$2.0M990,5803.7%